Stand: 25.07.2026 05:30 Uhr
| vom
The new weight loss pill Wegovy, containing the active ingredient Semaglutide, is now available for the treatment of obesity. How effective is the tablet? What side effects exist? Who will cover the costs?
## Understanding Wegovy: The Mechanism of Semaglutide
Wegovy, containing Semaglutide, is a member of the GLP-1 receptor agonists. This class of medications mimics a hormone in the gut that signals the brain to reduce appetite and promotes a feeling of fullness. Additionally, Semaglutide encourages insulin secretion, helping to regulate blood sugar levels.
But there’s a crucial difference between the injection and the pill form: while the injection delivers the drug directly to subcutaneous fat tissue, the tablet must first traverse the stomach, where stomach acid can degrade Semaglutide. Therefore, the tablet formulation includes an absorption enhancer to ensure that sufficient amounts of the drug enter the bloodstream.
### Effectiveness and Weight Loss
Research indicates that participants using the Semaglutide pill can achieve weight losses comparable to those observed with injections. In a pivotal study known as the OASIS-4 trial, participants lost an average of 16.6% of their body weight when following the prescribed regimen. However, individual results may vary significantly.
Experts suggest that while the pill represents an important addition to obesity treatment options, it is not a new mechanism. Instead, it offers an alternative for those who may have a fear of needles or prefer oral medication.
## Pill Adherence: A Key to Success
The Semaglutide pill presents a promising option for individuals with obesity who avoid injections. However, it requires strict adherence to dosing instructions: the tablet must be taken on an empty stomach with minimal water, followed by a thirty-minute period during which no food, beverages, or other medications can be consumed. For those on multiple medications, this may present challenges, as not adhering closely to these instructions could lead to lower drug absorption and diminished effectiveness.
### Side Effects and Considerations
Clinical data shows that the side effects of the pill are similar to those experienced with the injection. The most commonly reported issues are gastrointestinal disturbances, such as nausea and digestive discomfort. Many of these symptoms tend to manifest early in the treatment but often subside over time.
Both the injection and the pill require ongoing medication. If individuals do not make concurrent changes to their diet and activity levels while using these medications, a rebound effect—essentially regaining lost weight—can occur after discontinuation.
## Target Audience for Wegovy
This medication is designed for adults with severe obesity, particularly those with a Body Mass Index (BMI) of 30 or higher, or a BMI of 27 and above if they have associated conditions like hypertension, sleep apnea, cardiovascular diseases, or Type 2 diabetes.
It is crucial to note that Wegovy is not intended for weight loss for cosmetic reasons or short-term needs. Experts caution against potential misuse because the pill may seem more benign than an injection.
## Final Thoughts: A New Dawn for Obesity Treatment
Wegovy brings hope to many struggling with obesity, serving as an essential tool in the fight against excess weight. While it is not a magic solution, combining this medication with lifestyle changes like diet and exercise offers the best chances for long-term success.
As research evolves and more individuals share their experiences with Wegovy, it remains a focal point in discussions about innovative approaches to tackling obesity in today’s society.
